See All Slides -

Slides

Presentation TCT 2012

CCTRN: Second Cycle Studies

Presenter: Emerson Perin

October 22, 2012

Presentation TCT 2012

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Presenter: Jeffrey Popma

October 22, 2012

Presentation TCT 2012

Position 4. Patient Preference Matters: Use PCI with DES Early and Liberally in Most Patients!

Presenter: Ajay Kirtane

October 22, 2012

Presentation TCT 2012

The Epidemiology of Valvular Aortic Stenosis in the 21st Century

Presenter: Vuyisile Nkomo

October 22, 2012

Presentation TCT 2012

“Direct” Aortic Access is Easier, Safer, and Should be the Preferred Access Alternative!

Presenter: Michael Reardon

October 22, 2012

Presentation TCT 2012

Updates from the Worldwide Valve-in-Valve TAVR Registry

Presenter: Danny Dvir

October 22, 2012

Presentation TCT 2012

Improved Patient Screening, Meticulous Access and Closure Techniques, and Lower Profile Catheter Systems Can Reduce Major Vascular Complications to <5%: The Vancouver Experience

Presenter: John Webb

October 22, 2012

Presentation TCT 2012

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Pro!

Presenter: Mehdi Shishehbor

October 22, 2012

Presentation TCT 2012

Assessment: Hospital Administrator

Presenter: Michael Guiry

October 22, 2012

Presentation TCT 2012

CTO Case Volumes and the Learning Curve: Insights from the European CTO Registry

Presenter: Carlo Di Mario

October 22, 2012

Advertisement

Slides

CCTRN: Second Cycle Studies

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Position 4. Patient Preference Matters: Use PCI with DES Early and Liberally in Most Patients!

The Epidemiology of Valvular Aortic Stenosis in the 21st Century

“Direct” Aortic Access is Easier, Safer, and Should be the Preferred Access Alternative!

Updates from the Worldwide Valve-in-Valve TAVR Registry

Improved Patient Screening, Meticulous Access and Closure Techniques, and Lower Profile Catheter Systems Can Reduce Major Vascular Complications to <5%: The Vancouver Experience

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Pro!

Assessment: Hospital Administrator

CTO Case Volumes and the Learning Curve: Insights from the European CTO Registry

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content